&NA; Autophagy and apoptosis are commonly involved in the dopaminergic neuron damage in the pathogenesis of Parkinson's disease. Recently, the autophagy pathway is thought to be critical to the process… Click to show full abstract
&NA; Autophagy and apoptosis are commonly involved in the dopaminergic neuron damage in the pathogenesis of Parkinson's disease. Recently, the autophagy pathway is thought to be critical to the process of PD. Therefore, the regulation of autophagy may be a potential strategy for PD treatment. Mesencephalic astrocyte‐derived neurotrophic factor (MANF) has been reported to have neuroprotective effects through anti‐apoptosis, anti‐oxidative, and anti‐inflammatory mechanisms in PD. In this study, we investigated the role of autophagy system in MANF‐mediated neuroprotection against 6‐hydroxydopamine (6‐OHDA)‐induced neurotoxicity. Our results showed that MANF protected SH‐SY5Y cells against 6‐OHDA‐induced cell viability decrease and apoptosis by inhibiting autophagy. Mitochondrion damage and energetic dysfunction triggered by reactive oxidative stress (ROS) accumulation were also alleviated by MANF treatment. Furthermore, MANF downregulated phosphorylation of AMP‐activated protein kinase (AMPK), a cellular energy sensor and regulator, but upregulated phosphorylation of Mammalian target of rapamycin (mTOR) under energy depletion conditions, indicating AMPK/mTOR signaling pathway is involved in the autophagic inhibition of MANF. These results suggest that autophagic inhibition provides protective mechanism of MANF in 6‐OHDA‐induced SH‐SY5Y cell death and this inhibition is associated with AMPK/mTOR pathway. HighlightsMANF protected against 6‐OHDA‐induced SH‐SY5Y cell death.MANF protected against 6‐OHDA induced cell damage via autophagic inhibition.AMPK/mTOR signaling pathway was involved in the autophagic inhibition of MANF under oxidative stress.
               
Click one of the above tabs to view related content.